Pneumocystis carinii pneumonia treatment in people infected with HIV.
Identifieur interne : 000684 ( PubMed/Checkpoint ); précédent : 000683; suivant : 000685Pneumocystis carinii pneumonia treatment in people infected with HIV.
Auteurs : Richard Bellamy [Ghana]Source :
- Clinical evidence [ 1462-3846 ] ; 2004.
Descripteurs français
- KwdFr :
- Antifongiques (usage thérapeutique), Association de médicaments, Association triméthoprime-sulfaméthoxazole (usage thérapeutique), Atovaquone, Clindamycine (usage thérapeutique), Dapsone (usage thérapeutique), Humains, Infections à VIH (), Naphtoquinones (usage thérapeutique), Pentamidine (administration et posologie), Pentamidine (usage thérapeutique), Pneumonie à Pneumocystis (traitement médicamenteux), Primaquine (usage thérapeutique).
- MESH :
- administration et posologie : Pentamidine.
- traitement médicamenteux : Pneumonie à Pneumocystis.
- usage thérapeutique : Antifongiques, Association triméthoprime-sulfaméthoxazole, Clindamycine, Dapsone, Naphtoquinones, Pentamidine, Primaquine.
- Association de médicaments, Atovaquone, Humains, Infections à VIH.
English descriptors
- KwdEn :
- Antifungal Agents (therapeutic use), Atovaquone, Clindamycin (therapeutic use), Dapsone (therapeutic use), Drug Therapy, Combination, HIV Infections (complications), Humans, Naphthoquinones (therapeutic use), Pentamidine (administration & dosage), Pentamidine (therapeutic use), Pneumonia, Pneumocystis (drug therapy), Primaquine (therapeutic use), Trimethoprim, Sulfamethoxazole Drug Combination (therapeutic use).
- MESH :
- chemical , administration & dosage : Pentamidine.
- chemical , therapeutic use : Antifungal Agents, Clindamycin, Dapsone, Naphthoquinones, Pentamidine, Primaquine, Trimethoprim, Sulfamethoxazole Drug Combination.
- chemical : Atovaquone.
- complications : HIV Infections.
- drug therapy : Pneumonia, Pneumocystis.
- Drug Therapy, Combination, Humans.
PubMed: 15652046
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:15652046Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pneumocystis carinii pneumonia treatment in people infected with HIV.</title>
<author><name sortKey="Bellamy, Richard" sort="Bellamy, Richard" uniqKey="Bellamy R" first="Richard" last="Bellamy">Richard Bellamy</name>
<affiliation wicri:level="1"><nlm:affiliation>Kintampo Health Research Centre, Kintampo, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Kintampo Health Research Centre, Kintampo</wicri:regionArea>
<wicri:noRegion>Kintampo</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15652046</idno>
<idno type="pmid">15652046</idno>
<idno type="wicri:Area/PubMed/Corpus">000827</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000827</idno>
<idno type="wicri:Area/PubMed/Curation">000827</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000827</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000827</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000827</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Pneumocystis carinii pneumonia treatment in people infected with HIV.</title>
<author><name sortKey="Bellamy, Richard" sort="Bellamy, Richard" uniqKey="Bellamy R" first="Richard" last="Bellamy">Richard Bellamy</name>
<affiliation wicri:level="1"><nlm:affiliation>Kintampo Health Research Centre, Kintampo, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Kintampo Health Research Centre, Kintampo</wicri:regionArea>
<wicri:noRegion>Kintampo</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Clinical evidence</title>
<idno type="ISSN">1462-3846</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antifungal Agents (therapeutic use)</term>
<term>Atovaquone</term>
<term>Clindamycin (therapeutic use)</term>
<term>Dapsone (therapeutic use)</term>
<term>Drug Therapy, Combination</term>
<term>HIV Infections (complications)</term>
<term>Humans</term>
<term>Naphthoquinones (therapeutic use)</term>
<term>Pentamidine (administration & dosage)</term>
<term>Pentamidine (therapeutic use)</term>
<term>Pneumonia, Pneumocystis (drug therapy)</term>
<term>Primaquine (therapeutic use)</term>
<term>Trimethoprim, Sulfamethoxazole Drug Combination (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antifongiques (usage thérapeutique)</term>
<term>Association de médicaments</term>
<term>Association triméthoprime-sulfaméthoxazole (usage thérapeutique)</term>
<term>Atovaquone</term>
<term>Clindamycine (usage thérapeutique)</term>
<term>Dapsone (usage thérapeutique)</term>
<term>Humains</term>
<term>Infections à VIH ()</term>
<term>Naphtoquinones (usage thérapeutique)</term>
<term>Pentamidine (administration et posologie)</term>
<term>Pentamidine (usage thérapeutique)</term>
<term>Pneumonie à Pneumocystis (traitement médicamenteux)</term>
<term>Primaquine (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Pentamidine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antifungal Agents</term>
<term>Clindamycin</term>
<term>Dapsone</term>
<term>Naphthoquinones</term>
<term>Pentamidine</term>
<term>Primaquine</term>
<term>Trimethoprim, Sulfamethoxazole Drug Combination</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Atovaquone</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Pentamidine</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Pneumonia, Pneumocystis</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Pneumonie à Pneumocystis</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antifongiques</term>
<term>Association triméthoprime-sulfaméthoxazole</term>
<term>Clindamycine</term>
<term>Dapsone</term>
<term>Naphtoquinones</term>
<term>Pentamidine</term>
<term>Primaquine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Association de médicaments</term>
<term>Atovaquone</term>
<term>Humains</term>
<term>Infections à VIH</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15652046</PMID>
<DateCreated><Year>2005</Year>
<Month>01</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted><Year>2005</Year>
<Month>04</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1462-3846</ISSN>
<JournalIssue CitedMedium="Print"><Issue>11</Issue>
<PubDate><Year>2004</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Clinical evidence</Title>
<ISOAbbreviation>Clin Evid</ISOAbbreviation>
</Journal>
<ArticleTitle>Pneumocystis carinii pneumonia treatment in people infected with HIV.</ArticleTitle>
<Pagination><MedlinePgn>935-50</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bellamy</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Kintampo Health Research Centre, Kintampo, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Clin Evid</MedlineTA>
<NlmUniqueID>100883600</NlmUniqueID>
<ISSNLinking>1462-3846</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000935">Antifungal Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009285">Naphthoquinones</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>3U02EL437C</RegistryNumber>
<NameOfSubstance UI="D002981">Clindamycin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>673LC5J4LQ</RegistryNumber>
<NameOfSubstance UI="D010419">Pentamidine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>8064-90-2</RegistryNumber>
<NameOfSubstance UI="D015662">Trimethoprim, Sulfamethoxazole Drug Combination</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>8W5C518302</RegistryNumber>
<NameOfSubstance UI="D003622">Dapsone</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>MVR3634GX1</RegistryNumber>
<NameOfSubstance UI="D011319">Primaquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>Y883P1Z2LT</RegistryNumber>
<NameOfSubstance UI="D053626">Atovaquone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Clin Evid. 2005 Jun;(13):854-68</RefSource>
<PMID Version="1">16135282</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000935" MajorTopicYN="N">Antifungal Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053626" MajorTopicYN="N">Atovaquone</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002981" MajorTopicYN="N">Clindamycin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003622" MajorTopicYN="N">Dapsone</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009285" MajorTopicYN="N">Naphthoquinones</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010419" MajorTopicYN="N">Pentamidine</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011020" MajorTopicYN="N">Pneumonia, Pneumocystis</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011319" MajorTopicYN="N">Primaquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015662" MajorTopicYN="N">Trimethoprim, Sulfamethoxazole Drug Combination</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>25</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>1</Month>
<Day>18</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>4</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>1</Month>
<Day>18</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15652046</ArticleId>
<ArticleId IdType="pii">2501</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Ghana</li>
</country>
</list>
<tree><country name="Ghana"><noRegion><name sortKey="Bellamy, Richard" sort="Bellamy, Richard" uniqKey="Bellamy R" first="Richard" last="Bellamy">Richard Bellamy</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000684 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000684 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= SidaGhanaV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:15652046 |texte= Pneumocystis carinii pneumonia treatment in people infected with HIV. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:15652046" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SidaGhanaV1
This area was generated with Dilib version V0.6.31. |